Farmacologia_FMABC_News

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-chronic-hepatitis-delta-virus-hdv-infection

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-chronic-hepatitis-delta-virus-hdv-infection

FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.

1979 - Palestra de encerramento de Albert Sabin no Comuabc

Propagandas de "medicamentos" da época pré-científica da medicina

https://www1.folha.uol.com.br/equilibrioesaude/2026/04/eua-aprovam-foundayo-nova-pilula-para-emagrecer-da-mesma-fabricante-do-mounjaro.shtml

EUA aprovam Foundayo, nova pílula para emagrecer da mesma fabricante do Mounjaro Medicamento começa a ser vendido nesta segunda (6) nos EUA, mas ainda não há previsão para chegar ao Brasil

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease | NEJM Renizgamglogene autogedtemcel (reni-cel) is an investigational clustered regularly interspaced short palindromic repeats (CRISPR)–Cas12a gene-edited autologous hematopoietic stem-cell therapy. The ...

Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease - An Open-Label, Multicenter Randomized Clinical Trial

Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease This randomized clinical trial examines the safety and efficacy of guideline-recommended treatments for patients with heart failure with reduced ejection fraction caused by Chagas disease.

The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies

https://pmc.ncbi.nlm.nih.gov/articles/PMC12886472/?fbclid=IwdGRleAP_B0JleHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEeBGWD5N1ayh6c0qF2f6wKKROjxq2tPRJLZh0JF530yMpoeoQ3_lW-xMiraN4_aem_SE6ixgjHaPA95Y3QsOjibQ

The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by persistent airflow limitation and systemic inflammation, with accumulating evidence implicating gut microbiota dysbiosis as a key modulator of ...

Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial

Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial Implementation of an AI stethoscope in routine primary care did not significantly increase detection of heart failure or increase community-based diagnosis after 12 months of implementation. AI stethoscope use was independently associated with significantly higher detection rates of heart failure, a...

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota - Nature Communications Here, via a metagenomics analysis of population-based and disease cohorts, Vich Vila et al. study the impact of 41 commonly used medications on the taxonomic structures, metabolic potential and resistome of the gut microbiome, underscoring the importance of correcting for multiple drug use in m...

FDA approved drugs in 2025